Neuralink Plans 2026 High-Volume Production

Neuralink, co-founded by Elon Musk, announced plans to begin high-volume production of its brain-computer interface devices and transition to fully automated surgical procedures by 2026. This significant step follows the company's successful human trials, which began in 2024 after addressing initial safety concerns raised by the United States — Food and Drug Administration in 2022. The implant is designed to assist individuals with severe neurological conditions, such as spinal cord injuries and paralysis, enabling them to control digital tools through thought. The first patient, Noland Arbaugh, has demonstrated the device's potential by playing video games, browsing the internet, and controlling a cursor. By September 2025, 12 people worldwide had received Neuralink implants. The company also secured $650 million in funding in June, providing resources for expansion and large-scale production. This move aims to make the implants more widely available and the implantation process safer and more efficient.